NeutriSci International Inc.
NRXCF · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Market Cap | $1,211 | $1,843 | $1,974 | $2,216 |
| - Cash | $2 | $2 | $2 | $175 |
| + Debt | $212 | $205 | $154 | $179 |
| Enterprise Value | $1,421 | $2,045 | $2,126 | $2,219 |
| Revenue | $3 | $3 | $3 | $51 |
| % Growth | -8.7% | -3.4% | -94% | – |
| Gross Profit | $2 | $2 | $2 | -$32 |
| % Margin | 62.1% | 77.5% | 65.2% | -63.2% |
| EBITDA | -$88 | -$129 | -$105 | -$208 |
| % Margin | -3,236.2% | -4,329.9% | -3,380.1% | -407.3% |
| Net Income | -$97 | -$138 | -$99 | -$218 |
| % Margin | -3,563.5% | -4,620.1% | -3,213% | -425.5% |
| EPS Diluted | -0.001 | -0.001 | -0.001 | -0.001 |
| % Growth | 37.5% | -33.3% | 50% | – |
| Operating Cash Flow | -$6 | -$49 | -$149 | -$61 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$6 | -$49 | -$149 | -$61 |